Company Quick10K Filing
Processa Pharmaceuticals
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-05
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-06
S-1 2019-12-13 Public Filing
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-28
10-Q 2018-09-30 Filed 2018-11-14
S-1 2018-07-30 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-10-04
10-Q 2017-03-31 Filed 2017-10-04
10-K 2016-12-31 Filed 2017-09-25
10-Q 2016-09-30 Filed 2017-09-08
10-Q 2016-06-30 Filed 2017-08-30
10-Q 2016-03-31 Filed 2017-08-07
10-K 2015-12-31 Filed 2017-06-19
10-Q 2015-09-30 Filed 2015-12-01
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-14
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-27
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-08
8-K 2020-11-03
8-K 2020-10-06
8-K 2020-10-01
8-K 2020-08-23
8-K 2020-08-20
8-K 2020-06-01
8-K 2020-05-27
8-K 2020-03-30
8-K 2020-03-17
8-K 2020-03-05
8-K 2020-02-25
8-K 2020-02-13
8-K 2020-01-14
8-K 2019-12-19
8-K 2019-10-23
8-K 2019-09-20
8-K 2019-09-04
8-K 2019-06-19
8-K 2019-06-07
8-K 2019-03-13
8-K 2019-02-25
8-K 2019-01-09
8-K 2018-12-06
8-K 2018-10-02
8-K 2018-09-05
8-K 2018-06-29
8-K 2018-06-04
8-K 2018-05-25
8-K 2018-03-19

Processa Pharmaceuticals Financials

PCSA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,0021878240562142151522157322802,8471,7772,8502,4241,7411,249722504
Accounts Receivable2419209927451512
Inventory207228264206201222197203141
PP&E447447568570630652654642348192929292917152929
Assets3,8432,9382,9082,7852,6672,5422,543878498104474335322802,98312,88614,43813,46313,21512,07811,30610,821
Accounts Payable10177831121451901782191911591691741711661799196511052518029228314365
Long-Term Debt28
Liabilities1,4661,2671,8782,1622,7831,3341,8412,1982,1162,0832,1652,2142,2852,3542,4392,4931152,6105,6103,1312,9573,5142,9542,8042,151
Stockholders' Equity2,3771,6711,030623-1171,208702-1,320-1,618-1,979-2,118-2,170-2,250-2,351-2,437-2,491-353737,27611,30710,5069,7019,1248,5028,671
Income Statement ($'000)2013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue12670201135314472058-115-53000
Cost of Revenue8070970259291143430-4300
Gross Profit450114327617916-545-1100
R&D55771006812101411226100009268081,078612485727585
SG&A664752805712677650602467119-24381341410164484690452398410419
Tax-0-0-0-0-0-0-0-0-0-22-282-278-212-130-171-141
Net Income-719-807-1,344-851-792-1,539-645-2,051-296-363-134-43-68-91-76-43-204-634-1,097-1,206-853-751-969-864
Cash Flow ($'000)2013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-463-988-708-540-459-502-277-47-46-44-317-7-2-75-174-1,405-1,069-1,164-1,011-492-527-218
Cash Investing84-10-2-10-23-100422715-250-2-496476000
Cash Financing-430894668566447524250470150002522,0981090